CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Guizhou Bailing Group Pharmaceutical Company Limited Company Snapshot
Guizhou Bailing Group Pharmaceutical Company Limited operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Guizhou Bailing Group Pharmaceutical Company Limited with three other companies in this sector in China: Hengkang Medical Group Co Ltd (2016 sales of 2.18 billion Chinese Renmimbi [US$316.07 million] of which 57% was Service), Mayinglong Pharmaceutical Group Co Ltd (2.10 billion Chinese Renmimbi [US$305.52 million] of which 48% was Pharmaceutical Circulation), and Zhangzhou Pientzehuang Pharmaceutical Company Ltd (2.31 billion Chinese Renmimbi [US$335.47 million] of which 48% was Pharmaceutical Manufacturing).

Sales Analysis. During the year ended December of 2016, sales at Guizhou Bailing Group Pharmaceutical Company Limited were 2.21 billion Chinese Renmimbi (US$321.75 million). This is an increase of 16.6% versus 2015, when the company's sales were 1.90 billion Chinese Renmimbi. This was the fifth consecutive year of sales increases at Guizhou Bailing Group Pharmaceutical Company Limited (and since 2011, sales have increased a total of 94%). Sales of Business saw an increase that was more than double the company's growth rate: sales were up 144.2% in 2016, from 95.17 million Chinese Renmimbi to 232.36 million Chinese Renmimbi. Not all segments of Guizhou Bailing Group Pharmaceutical Company Limited experienced an increase in sales in 2016: sales of Other fell 55.6% to 12.13 million Chinese Renmimbi. (However, this segment's sales were only a very small portion of the company's overall sales).
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Guizhou Bailing Group Pharmaceutical Company Limited
  Stock Performance Chart for Guizhou Bailing Group Pharmaceutical Company Limited
 
  Stock Data: Recent Stock Performance:
  Current Price (5/19/2017): 16.14
(Figures in Chinese Renmimbi)
1 Week 1.5%   13 Weeks -5.4%  
4 Weeks -11.2%   52 Weeks 0.9%  
 
Guizhou Bailing Group Pharmaceutical Company Limited Key Data:
  Ticker: 002424 Country: China
  Exchanges: SZN Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2016 Sales 2,214,211,074
(Year Ending Jan 2017).
Employees: 4,928
  Currency: Chinese Renmimbi Market Cap: 22,776,768,000
  Fiscal Yr Ends: December Shares Outstanding: 1,411,200,000
  Share Type: A Gu Closely Held Shares: 1,034,446,225
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.